Synthetic production of the naturally occurring anti-cancer medicine paclitaxel may be one step closer with the discovery of the enzymes responsible for producing baccatin III, a complex precursor in the biosynthesis of the drug. Previous methods for synthesising paclitaxel in the lab take up to 30 steps, the use of hazardous reagents and sourcing of […]
Read More